在缺血性心脏中探索hiPSC-CM替代疗法.
Giuseppe Cipriano1, Thomas Thum1, Natalie Weber2,3
1Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625, Hannover, Germany.
Basic research in cardiology
|June 10, 2025
概括
心血管研究正在探索再生心脏损伤后的新方法,重点是细胞疗法,如诱导多能干细胞衍生的心肌细胞 (iPSC-CMs),以取代丢失的心脏细胞并改善功能.
科学领域:
- 心血管研究研究心血管研究
- 再生医学是一种再生医学.
- 心脏细胞疗法心脏细胞疗法
背景情况:
- 缺血性心脏病导致全球心力衰竭和死亡.
- 心肌梗塞导致心肌细胞损失,导致心脏重塑和失败.
- 目前的治疗方法减缓了重塑,但没有解决心肌细胞损失或再生的问题.
研究的目的:
- 审查心脏细胞治疗心脏再生的演变.
- 为了突出最近在取代丢失的心肌细胞方面的进展.
- 讨论将细胞治疗转化为临床实践的挑战.
主要方法:
- 研究非编码RNA操纵 (lncRNA,circRNA,miRNA) 的研究.
- 利用生长因子促进心肌细胞细胞循环重新进入.
- 探索纤维细胞直接重新编程成心肌细胞 (CMs).
- 开发诱导多能干细胞 (iPSC) 重编程和分化协议,以产生iPSC衍生的心肌细胞 (iPSC-CMs).
- 通过抗亡策略和组织工程来增强iPSC-CM疗法.
主要成果:
- 诱导多能干细胞 (iPSC) 和iPSC衍生的心肌细胞 (iPSC-CM) 为心脏再生提供了希望.
- 在生成纯 iPSC-CM 种群方面取得了显著进展.
- 关于细胞存活,保留,心律失常性和免疫反应的挑战仍然存在.
结论:
- 心脏细胞疗法,特别是使用iPSC-CMs,是心脏再生的一个有希望的方法.
- 克服细胞移植,安全性和免疫反应方面的挑战对于临床翻译至关重要.
- 继续研究提高细胞疗法的疗效和安全性对于治疗心力衰竭至关重要.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
67
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
67
01:29Cardiomyopathy V: Interprofessional Care
41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
44
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
44